3 days ago
Novo Nordisk (NVO) Stock: Pharma Giant Inks $1.4B Partnership With Orbis for AI-Driven Oral Therapies
Novo Nordisk (NVO) announces $1.4B partnership with Orbis Medicines to develop oral therapies for cardiometabolic diseases using AI-powered technology.
The post Novo Nordisk (NVO) Stock: Pharma Giant Inks $1.4B Partnership With Orbis for AI-Driven Oral Therapies appeared first on Blockonomi.
Source: Blockonomi →Related News
- 1 day ago
Dow Slides for Third Week as 10-Year Treasury Yield Approaches 5% Mark
- 1 day ago
UBS Highlights Palantir (PLTR), AT&T (T), and Spotify (SPOT) as Premier Tech Inv...
- 1 day ago
SpaceX (SPCX) Stock Dips Despite Securing Nearly $1 Billion NASA Contract
- 1 day ago
Anthropic Eyes AI Model Release Ahead of Potential $2 Trillion November IPO
- 1 day ago
Avalanche Blockchain Under Year-Long Evaluation by NYSE for Digital Securities P...